I received the following information in an email about the upcoming release of Exjade in India. Contact information is included. I would just like to remind everyone that is essential that Exjade be taken ONLY under a doctor's REGULAR supervision, with adequate monitoring of kidney and liver levels.
We expect Tab.Asunra ( globally known as Exjade) will
begin to be available in the India during the second
quarter of 2008
Please consult your physician in the first week of
April
Regards.
D. Mohan
Product Manager
Novartis India Limited
Sandoz House, 7th floor
Shivsagar Estate
Dr. Annie Besant Road
India
Phone: +91 22 24988888
Cell: ++ 91 9821777242
Email : mohan.devadiga@novartis.com